Zobrazeno 1 - 10
of 39
pro vyhledávání: ''
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Autor:
Jinyi Wang, Guohan Chen, Guangxue Wang, Xuan Hong, Zhiyuan Huang, Tian Zhao, Yejun Cao, Qiying Zhang, Zhengjun Chai, Jie Liu, Qinchuan Li, Yang Han, Zhengliang Sun
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Objective The aim of this study was to assess the efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy (IPHC) in treating malignant pleural effusion (MPE) compared to normothermic chemoperfusion of the pleural cavity (NCPC), a
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8909-8923 (2021)
Cancer Medicine
Cancer Medicine
Background There is limited and controversial evidence on the prognosis of partial nephrectomy (PN) versus radical nephrectomy (RN) in patients with T3aN0/xM0 renal cell carcinoma (RCC) upstaged from clinical T1 RCC. In this study, we aimed to assess
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 128-138 (2022)
Objective To investigate whether surgery improves prognosis in elderly patients with Merkel cell carcinoma (MCC). Materials/Methods Data of all patients with MCC diagnosed between 2004 and 2015 were extracted from the Surveillance, Epidemiology, and
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Purpose To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival. Methods Surveillance, Epid
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 21, Pp 7988-8003 (2020)
Cancer Medicine, Vol 9, Iss 21, Pp 7988-8003 (2020)
Objective To compare the survival outcomes of local ablation (LA) and partial nephrectomy (PN) for T1N0M0 renal cell carcinoma (RCC). Method We identified 38,155 T1N0M0 RCC patients treated with PN or LA in 2004‐2016 from the retrospective Surveill
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6638-6645 (2020)
Cancer Medicine
Cancer Medicine
Background The role of surgery and chemotherapy for stage IV small bowel adenocarcinoma (SBA) is still confused. The results from previous analyses have been limited by small sample sizes and different treatment regimens. Methods Patients with stage
Autor:
Hans Christian Reinhardt, Maike Wittersheim, Roland Goldbrunner, Stephanie T Jünger, Stefan Grau, Petra Schödel, Nils-Ole Schmidt, Martin Proescholdt
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7503-7510 (2020)
Cancer Medicine
Cancer Medicine
Background Brain metastases (BM) frequently cause focal neurological deficits leading to a reduced Karnofsky performance score (KPS). Since KPS is routinely used to guide the choice of adjuvant therapy, we hypothesized that improving KPS by surgical
Autor:
Jun Chen, Xiongfei Li, Song Xu, Yanye Wang, Ming Dong, Dian Ren, Gang Chen, Fan Ren, Zuoqing Song
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7686-7694 (2020)
Cancer Medicine
Cancer Medicine
Background The prognostic factors for early‐stage nonsmall cell lung cancers (NSCLCs) are not well defined. This study aimed to investigate the effect of highly frequent mutations on the outcomes patients with early‐stage NSCLC, particularly thos
Autor:
Edmund Folefac, Paul Monk, Amir Mortazavi, Steven K. Clinton, Ming Yin, Douglas Martin, Claire F. Verschraegen, Monika Joshi, Jing Zhao, Ning Jin
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 27-34 (2020)
Cancer Medicine
Cancer Medicine
Background It remains controversial if radical prostatectomy or definitive radiation therapy produces equivalent outcomes in high‐risk localized prostate cancer. Methods We queried The Surveillance, Epidemiology, and End Results (SEER) database for